login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
APOLLOMICS INC (APLM) Stock News
USA
- NASDAQ:APLM -
KYG0411D1236
-
Common Stock
24.54
USD
+3.58 (+17.08%)
Last: 11/14/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
APLM Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: Benzinga
- Mentions:
ZYXI
MRSN
CMND
OTLK
...
12 Health Care Stocks Moving In Thursday's Intraday Session
12 days ago - By: Benzinga
- Mentions:
ZOOZ
EPWK
TAIT
WAI
...
Why Lucas GC Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket
a month ago - By: Stocktwits
Why Apollomics Stock Nosedived 16% After-Hours Today
a month ago - By: Apollomics Inc.
聽證會取消後,Apollomics 宣佈繼續於 The Nasdaq Stock Market 維持其上市地位
a month ago - By: Apollomics Inc.
Apollomics 宣布听证会取消后继续在 Nasdaq 股票市场上市
a month ago - By: Apollomics Inc.
Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation
a month ago - By: Apollomics Inc.
Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation
a month ago - By: Apollomics Inc.
Apollomics, Inc. 公司營運持續性最新消息
a month ago - By: Apollomics Inc.
Apollomics, Inc. Company Operational Continuity Update
a month ago - By: Apollomics Inc.
Apollomics, Inc. Company Operational Continuity Update
8 months ago - By: Apollomics Inc.
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
8 months ago - By: Apollomics Inc.
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
8 months ago - By: Apollomics Inc.
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
8 months ago - By: Apollomics Inc.
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
a year ago - By: Apollomics Inc.
Apollomics 公布 Uproleselan 在中國治療復發或難治性急性髓系白血病患者的第 3 期銜接性試驗的主要結果
a year ago - By: Apollomics Inc.
Apollomics 公布在中国对复发或难治性急性髓系白血病患者进行的 Uproleselan III 期桥接试验主要结果
a year ago - By: Apollomics Inc.
Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia
a year ago - By: Apollomics Inc.
Apollomics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
a year ago - By: Apollomics Inc.
Apollomics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
a year ago - By: Apollomics Inc.
Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split
a year ago - By: Apollomics Inc.
Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split
Please enable JavaScript to continue using this application.